Etoricoxib: Is a selective cyclo-oxygenase enzyme

Etoricoxib is a selective cyclo-oxygenase enzyme (COX-2) inhibitor that reduces the production of prostaglandins from arachidonic acid. Prostaglandins affect our physiological processes, such as inflammation and blood flow. Thus, Etoricoxib breaks the pain pathway. Etoricoxib is a painkiller medicine. It provides relief from pain, stiffness, and swelling due to various conditions like ankylosing spondylitis (pain and stiffness of bones of the spine), osteoarthritis (tender and painful joints due to wear down of protective cartilage between the ends of the bones), rheumatoid arthritis (swelling and pain in the small joints of your body), etc. It is also used to relieve pain after dental surgery. Etoricoxib works by preventing the release of a chemical ... Etoricoxib is a selective COX-2 inhibitor used to relieve moderate post-surgical dental pain as a short-term treatment and inflammatory and painful symptoms of various forms of arthritis. Etoricoxib is an Analgesic a belonging to the class Cyclooxygenase-2 (COX-2) inhibitor / non-steroidal anti-inflammatory drugs (NSAIDs). Etoricoxib is a COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins ...